Your browser doesn't support javascript.
Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India.
Kute, Vivek B; Bhalla, Anil K; Guleria, Sandeep; Ray, Deepak S; Bahadur, Madan M; Shingare, Ashay; Hegde, Umapati; Gang, Sishir; Raju, Sreebhushan; Patel, Himanshu V; Jain, Siddharth; Godara, Suraj; Modi, Pranjal; Gumber, Manoj; Engineer, Divyesh P; Dalal, Sonal; Darji, Prakash; Balwani, Manish; Patel, Ansy H; Mishra, Vineet V.
  • Kute VB; Department of Nephrology, Institute of Kidney Diseases and Research Center, Dr. HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujrat, India.
  • Bhalla AK; Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, Delhi, India.
  • Guleria S; Department of Transplantation Surgery, Indraprastha Apollo Hospital, New Delhi, Delhi, India.
  • Ray DS; Department of Nephrology, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, West Bengal, India.
  • Bahadur MM; Department of Nephrology, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India.
  • Shingare A; Department of Nephrology, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India.
  • Hegde U; Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India.
  • Gang S; Department of Nephrology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India.
  • Raju S; Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
  • Patel HV; Department of Nephrology, Institute of Kidney Diseases and Research Center, Dr. HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujrat, India.
  • Jain S; Department of Nephrology, Kidney Care Clinic, Surat, Gujarat, India.
  • Godara S; Department of Nephrology, Mahatma Gandhi Medical College & Hospital, Jaipur, Rajasthan, India.
  • Modi P; Department of Transplantation Surgery, IKDRC-ITS, Ahmedabad, Gujrat, India.
  • Gumber M; Department of Nephrology, Apollo Hospitals International Limited, Gandhi Nagar, Ahmedabad, Gujarat, India.
  • Engineer DP; Department of Nephrology, Institute of Kidney Diseases and Research Center, Dr. HL Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujrat, India.
  • Dalal S; Department of Nephrology, Gujarat Kidney Foundation, Ahmedabad, Gujarat, India.
  • Darji P; Department of Nephrology, Zydus Hospitals, Ahmedabad, Gujarat, India.
  • Balwani M; Department of Nephrology, Jawaharlal Nehru Medical College, Wardha, Maharashtra, India.
  • Patel AH; BJ Medical College, Civil Hospital, Ahmedabad, Gujarat, India.
  • Mishra VV; IKDRC-ITS, Ahmedabad, Gujarat, India.
Transplantation ; 105(4): 851-860, 2021 04 01.
Article in English | MEDLINE | ID: covidwho-991012
ABSTRACT

BACKGROUND:

There is a scarcity of data on the consequences of coronavirus disease-19 (COVID-19) infections in kidney transplant recipients (KTRs) from emerging countries.

METHODS:

Here, we present a cohort study of 13 transplant centers in India including 250 KTR (226 living and 24 deceased donors) with polymerase chain reaction-confirmed COVID-19 positivity from March 23, 2020, until September 15, 2020. We detailed demographics, immunosuppression regimen, clinical profile, treatment, and outcomes.

RESULTS:

Median age of transplant recipients was 43 years, and recipients presented at a median of 3.5 years after transplant. Most common comorbidities (94%) included arterial hypertension (84%) and diabetes (32%); presenting symptoms at the time of COVID-19 included fever (88%), cough (72%), and sputum production (52%). Clinical severity ranged from asymptomatic (6%), mild (60%), and moderate (20%) to severe (14%). Strategies to modify immunosuppressants included discontinuation of antimetabolites without changes in calcineurin inhibitors and steroids (60%). Risk factors for mortality included older age; dyspnea; severe disease; obesity; allograft dysfunction before COVID-19 infection; acute kidney injury; higher levels of inflammatory markers including C-reactive protein, interleukin-6 level, and procalcitonin; chest X-ray abnormality, and intensive care unit/ventilator requirements. Overall patient mortality was 11.6% (29 of 250), 14.5% (29 of 200) in hospitalized patients, 47% (25 of 53) in intensive care unit patients, and 96.7% (29 of 30) in patients requiring ventilation. KTRs with mild COVID-19 symptoms (n = 50) were managed as outpatients to optimize the utilization of scarce resources during the COVID-19 pandemic.

CONCLUSIONS:

Mortality rates in COVID-19-positive KTR appear to be higher than those in nonimmunosuppressed patients, and high mortality was noted among those requiring intensive care and those on ventilator.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Transplantation Year: 2021 Document Type: Article Affiliation country: TP.0000000000003593

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Transplantation Year: 2021 Document Type: Article Affiliation country: TP.0000000000003593